In 2025, China’s competition law regime actively responded to new issues and challenges arising from the changes of market competition.
In the realm of administrative enforcement, the focus remained on public utilities with specialized guidelines being issued for this sector; the “safe harbor” rule for vertical monopoly agreements was formally announced; and in a few cases involving abuse of dominance by active pharmaceutical ingredient (“API”) companies, the authority penalized both the companies and the key management personnel.